Status:
UNKNOWN
Vibrotactile Foot Device for Freezing of Gait in Parkinson's Disease
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Parkinson Disease
Freezing of Gait
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Freezing of gait (FOG) is a common, disabling symptom of later stage Parkinson's disease (PD), and can induce significant morbidity and mortality by increasing risk of falls as the disease progresses....
Eligibility Criteria
Inclusion
- Age 30-80 years
- Diagnosed with Parkinson's Disease according to MDS Clinical Diagnostic Criteria
- Stable drug therapy without any change in the past one month
- Subjective presence of FOG more than once per day
- Objective presence of FOG by provoking tasks, e.g., gait initiation, rapid full turn, et al.
- Able to walk unaided at least 20 meters
- Provide written informed consent
Exclusion
- Stroke and other diseases interfering ambulation
- Severe foot sensory impairments disabling the individual to perceive vibratory stimulation
- History of deep brain stimulation surgery
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06147713
Start Date
May 1 2022
End Date
November 1 2024
Last Update
February 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital
Beijing, China